25 XP   0   0   10

Universal Vision Biotechnology Co Ltd
Buy, Hold or Sell?

Let's analyse Universal Vision Biotechnology Co Ltd together

PenkeI guess you are interested in Universal Vision Biotechnology Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Universal Vision Biotechnology Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Universal Vision Biotechnology Co Ltd

I send you an email if I find something interesting about Universal Vision Biotechnology Co Ltd.

Quick analysis of Universal Vision Biotechnology Co Ltd (30 sec.)










What can you expect buying and holding a share of Universal Vision Biotechnology Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
NT$0.00
When do you have the money?
1 year
How often do you get paid?
60.0%

What is your share worth?

Current worth
NT$39.46
Expected worth in 1 year
NT$45.53
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
NT$6.08
Return On Investment
2.5%

For what price can you sell your share?

Current Price per Share
NT$240.50
Expected price per share
NT$192.37 - NT$259.81
How sure are you?
50%

1. Valuation of Universal Vision Biotechnology Co Ltd (5 min.)




Live pricePrice per Share (EOD)

NT$240.50

Intrinsic Value Per Share

NT$172.96 - NT$204.18

Total Value Per Share

NT$212.41 - NT$243.64

2. Growth of Universal Vision Biotechnology Co Ltd (5 min.)




Is Universal Vision Biotechnology Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$102.6m$76.5m$15.7m17.1%

How much money is Universal Vision Biotechnology Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$8m$6.5m$1.4m18.6%
Net Profit Margin25.6%24.3%--

How much money comes from the company's main activities?

3. Financial Health of Universal Vision Biotechnology Co Ltd (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#139 / 334

Most Revenue
#134 / 334

Most Profit
#63 / 334

What can you expect buying and holding a share of Universal Vision Biotechnology Co Ltd? (5 min.)

Welcome investor! Universal Vision Biotechnology Co Ltd's management wants to use your money to grow the business. In return you get a share of Universal Vision Biotechnology Co Ltd.

What can you expect buying and holding a share of Universal Vision Biotechnology Co Ltd?

First you should know what it really means to hold a share of Universal Vision Biotechnology Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Universal Vision Biotechnology Co Ltd is NT$240.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Universal Vision Biotechnology Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Universal Vision Biotechnology Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is NT$39.46. Based on the TTM, the Book Value Change Per Share is NT$1.52 per quarter. Based on the YOY, the Book Value Change Per Share is NT$1.47 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is NT$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Universal Vision Biotechnology Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 NT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per Share
Usd Eps0.090.0%0.090.0%0.080.0%0.060.0%0.030.0%
Usd Book Value Change Per Share0.060.0%0.050.0%0.050.0%0.030.0%0.020.0%
Usd Dividend Per Share0.000.0%0.000.0%0.070.0%0.060.0%0.040.0%
Usd Total Gains Per Share0.060.0%0.050.0%0.110.0%0.090.0%0.060.0%
Usd Price Per Share8.50-10.99-8.79-7.31-4.23-
Price to Earnings Ratio23.18-29.18-28.74-30.28-32.91-
Price-to-Total Gains Ratio138.37-52.60-88.95-67.11-88.93-
Price to Book Ratio7.02-10.30-9.81-8.75-5.60-
Price-to-Total Gains Ratio138.37-52.60-88.95-67.11-88.93-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share7.38335
Number of shares135
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.06
Usd Book Value Change Per Share0.050.03
Usd Total Gains Per Share0.050.09
Gains per Quarter (135 shares)6.3012.54
Gains per Year (135 shares)25.1850.14
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
102515331740
205040663490
30766510051140
401019013368190
5012611516685240
60151140199102290
70176165232119340
80201190265136390
90227215299153440
100252240332170490

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%54.00.09.085.7%
Book Value Change Per Share3.01.00.075.0%9.03.00.075.0%15.05.00.075.0%31.09.00.077.5%43.020.00.068.3%
Dividend per Share0.00.04.00.0%6.00.06.050.0%13.00.07.065.0%24.00.016.060.0%26.00.037.041.3%
Total Gains per Share3.01.00.075.0%11.01.00.091.7%19.01.00.095.0%36.04.00.090.0%48.015.00.076.2%

Fundamentals of Universal Vision Biotechnology Co Ltd

About Universal Vision Biotechnology Co Ltd

Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. Its clinic provides laser vision correction surgery for myopia, hyperopia, astigmatism, and presbyopia; intraocular lens surgery for presbyopia and cataract; phacoemulsification and femtosecond laser for cataract surgery; and myopia control services, as well as services for dry eyes, retinal detachment, macular degeneration, strabismus, amblyopia, and other eye diseases. The company also offers vision products and services, including a range of eyeglass frames, multifocal and progressive lenses for myopia and presbyopia, sunglasses, orthokeratology, rigid gas permeable lenses, regular/colored contact lenses, eye supplements, etc.; eye plastic and micro cosmetic surgery; and customized aesthetic medicine consulting. In addition, it engages in the provision of optometric, hospital management, and technical consultancy services; and sales and leasing of medical devices. Universal Vision Biotechnology Co., Ltd. was founded in 1992 and is based in Taipei, Taiwan.

Fundamental data was last updated by Penke on 2024-04-16 19:18:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of Universal Vision Biotechnology Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Universal Vision Biotechnology Co Ltd earns for each NT$1 of revenue.

  • Above 10% is considered healthy but always compare Universal Vision Biotechnology Co Ltd to the Medical Devices industry mean.
  • A Net Profit Margin of 25.5% means that NT$0.25 for each NT$1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Universal Vision Biotechnology Co Ltd:

  • The MRQ is 25.5%. The company is making a huge profit. +2
  • The TTM is 25.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ25.5%TTM25.6%-0.1%
TTM25.6%YOY24.3%+1.3%
TTM25.6%5Y22.5%+3.1%
5Y22.5%10Y16.4%+6.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ25.5%-12.4%+37.9%
TTM25.6%-20.4%+46.0%
YOY24.3%-14.8%+39.1%
5Y22.5%-21.3%+43.8%
10Y16.4%-25.0%+41.4%
1.1.2. Return on Assets

Shows how efficient Universal Vision Biotechnology Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Universal Vision Biotechnology Co Ltd to the Medical Devices industry mean.
  • 4.9% Return on Assets means that Universal Vision Biotechnology Co Ltd generated NT$0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Universal Vision Biotechnology Co Ltd:

  • The MRQ is 4.9%. Using its assets, the company is less efficient in making profit.
  • The TTM is 5.3%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ4.9%TTM5.3%-0.3%
TTM5.3%YOY5.1%+0.2%
TTM5.3%5Y4.2%+1.1%
5Y4.2%10Y2.8%+1.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.9%-4.1%+9.0%
TTM5.3%-4.7%+10.0%
YOY5.1%-4.8%+9.9%
5Y4.2%-4.0%+8.2%
10Y2.8%-5.2%+8.0%
1.1.3. Return on Equity

Shows how efficient Universal Vision Biotechnology Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Universal Vision Biotechnology Co Ltd to the Medical Devices industry mean.
  • 8.0% Return on Equity means Universal Vision Biotechnology Co Ltd generated NT$0.08 for each NT$1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Universal Vision Biotechnology Co Ltd:

  • The MRQ is 8.0%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 9.3%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ8.0%TTM9.3%-1.4%
TTM9.3%YOY9.1%+0.2%
TTM9.3%5Y7.4%+1.9%
5Y7.4%10Y4.8%+2.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ8.0%-4.2%+12.2%
TTM9.3%-5.8%+15.1%
YOY9.1%-5.7%+14.8%
5Y7.4%-6.3%+13.7%
10Y4.8%-7.1%+11.9%

1.2. Operating Efficiency of Universal Vision Biotechnology Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Universal Vision Biotechnology Co Ltd is operating .

  • Measures how much profit Universal Vision Biotechnology Co Ltd makes for each NT$1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Universal Vision Biotechnology Co Ltd to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated NT$0.00  for each NT$1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Universal Vision Biotechnology Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM8.0%-8.0%
TTM8.0%YOY31.1%-23.1%
TTM8.0%5Y27.5%-19.5%
5Y27.5%10Y14.7%+12.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--24.3%+24.3%
TTM8.0%-16.4%+24.4%
YOY31.1%-13.7%+44.8%
5Y27.5%-19.9%+47.4%
10Y14.7%-24.5%+39.2%
1.2.2. Operating Ratio

Measures how efficient Universal Vision Biotechnology Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.10 means that the operating costs are NT$1.10 for each NT$1 in net sales.

Let's take a look of the Operating Ratio trends of Universal Vision Biotechnology Co Ltd:

  • The MRQ is 1.097. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.078. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.097TTM1.078+0.020
TTM1.078YOY1.077+0.001
TTM1.0785Y1.118-0.041
5Y1.11810Y0.803+0.315
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0971.442-0.345
TTM1.0781.439-0.361
YOY1.0771.431-0.354
5Y1.1181.436-0.318
10Y0.8031.374-0.571

1.3. Liquidity of Universal Vision Biotechnology Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Universal Vision Biotechnology Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 2.52 means the company has NT$2.52 in assets for each NT$1 in short-term debts.

Let's take a look of the Current Ratio trends of Universal Vision Biotechnology Co Ltd:

  • The MRQ is 2.522. The company is able to pay all its short-term debts. +1
  • The TTM is 2.177. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.522TTM2.177+0.344
TTM2.177YOY2.092+0.085
TTM2.1775Y2.098+0.079
5Y2.09810Y1.243+0.854
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5222.726-0.204
TTM2.1772.732-0.555
YOY2.0923.510-1.418
5Y2.0983.617-1.519
10Y1.2433.499-2.256
1.3.2. Quick Ratio

Measures if Universal Vision Biotechnology Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Universal Vision Biotechnology Co Ltd to the Medical Devices industry mean.
  • A Quick Ratio of 1.14 means the company can pay off NT$1.14 for each NT$1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Universal Vision Biotechnology Co Ltd:

  • The MRQ is 1.136. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.071. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.136TTM1.071+0.065
TTM1.071YOY1.105-0.034
TTM1.0715Y1.117-0.045
5Y1.11710Y0.937+0.180
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1361.491-0.355
TTM1.0711.633-0.562
YOY1.1052.113-1.008
5Y1.1172.295-1.178
10Y0.9372.255-1.318

1.4. Solvency of Universal Vision Biotechnology Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Universal Vision Biotechnology Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Universal Vision Biotechnology Co Ltd to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.35 means that Universal Vision Biotechnology Co Ltd assets are financed with 34.8% credit (debt) and the remaining percentage (100% - 34.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Universal Vision Biotechnology Co Ltd:

  • The MRQ is 0.348. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.395. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.348TTM0.395-0.046
TTM0.395YOY0.406-0.012
TTM0.3955Y0.397-0.002
5Y0.39710Y0.355+0.041
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3480.389-0.041
TTM0.3950.386+0.009
YOY0.4060.335+0.071
5Y0.3970.442-0.045
10Y0.3550.461-0.106
1.4.2. Debt to Equity Ratio

Measures if Universal Vision Biotechnology Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Universal Vision Biotechnology Co Ltd to the Medical Devices industry mean.
  • A Debt to Equity ratio of 56.3% means that company has NT$0.56 debt for each NT$1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Universal Vision Biotechnology Co Ltd:

  • The MRQ is 0.563. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.706. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.563TTM0.706-0.143
TTM0.706YOY0.738-0.032
TTM0.7065Y0.707-0.001
5Y0.70710Y0.595+0.112
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5630.551+0.012
TTM0.7060.554+0.152
YOY0.7380.479+0.259
5Y0.7070.622+0.085
10Y0.5950.674-0.079

2. Market Valuation of Universal Vision Biotechnology Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every NT$1 in earnings Universal Vision Biotechnology Co Ltd generates.

  • Above 15 is considered overpriced but always compare Universal Vision Biotechnology Co Ltd to the Medical Devices industry mean.
  • A PE ratio of 23.18 means the investor is paying NT$23.18 for every NT$1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Universal Vision Biotechnology Co Ltd:

  • The EOD is 20.124. Based on the earnings, the company is fair priced.
  • The MRQ is 23.178. Based on the earnings, the company is fair priced.
  • The TTM is 29.185. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD20.124MRQ23.178-3.054
MRQ23.178TTM29.185-6.007
TTM29.185YOY28.742+0.442
TTM29.1855Y30.279-1.095
5Y30.27910Y32.908-2.628
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD20.124-1.077+21.201
MRQ23.178-1.704+24.882
TTM29.185-2.081+31.266
YOY28.742-2.978+31.720
5Y30.279-2.379+32.658
10Y32.908-1.726+34.634
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Universal Vision Biotechnology Co Ltd:

  • The EOD is 14.459. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 16.653. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 32.965. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD14.459MRQ16.653-2.194
MRQ16.653TTM32.965-16.312
TTM32.965YOY39.118-6.154
TTM32.9655Y39.256-6.292
5Y39.25610Y19.628+19.628
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD14.459-0.932+15.391
MRQ16.653-1.578+18.231
TTM32.965-2.973+35.938
YOY39.118-6.318+45.436
5Y39.256-5.307+44.563
10Y19.628-5.171+24.799
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Universal Vision Biotechnology Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 7.02 means the investor is paying NT$7.02 for each NT$1 in book value.

Let's take a look of the Price to Book Ratio trends of Universal Vision Biotechnology Co Ltd:

  • The EOD is 6.095. Based on the equity, the company is overpriced. -1
  • The MRQ is 7.020. Based on the equity, the company is overpriced. -1
  • The TTM is 10.303. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD6.095MRQ7.020-0.925
MRQ7.020TTM10.303-3.283
TTM10.303YOY9.806+0.497
TTM10.3035Y8.751+1.553
5Y8.75110Y5.599+3.151
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD6.0951.876+4.219
MRQ7.0202.372+4.648
TTM10.3032.434+7.869
YOY9.8063.217+6.589
5Y8.7513.893+4.858
10Y5.5994.245+1.354
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Universal Vision Biotechnology Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.0021.519+32%1.474+36%1.023+96%0.675+196%
Book Value Per Share--39.45735.482+11%29.417+34%26.104+51%20.569+92%
Current Ratio--2.5222.177+16%2.092+21%2.098+20%1.243+103%
Debt To Asset Ratio--0.3480.395-12%0.406-14%0.397-12%0.355-2%
Debt To Equity Ratio--0.5630.706-20%0.738-24%0.707-20%0.595-5%
Dividend Per Share----0%2.246-100%2.001-100%1.257-100%
Eps--2.9883.065-3%2.509+19%1.892+58%1.110+169%
Free Cash Flow Per Share--4.1583.185+31%2.288+82%2.188+90%2.188+90%
Free Cash Flow To Equity Per Share--4.1582.923+42%0.695+498%1.151+261%1.151+261%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--204.180--------
Intrinsic Value_10Y_min--172.956--------
Intrinsic Value_1Y_max--11.180--------
Intrinsic Value_1Y_min--10.976--------
Intrinsic Value_3Y_max--40.663--------
Intrinsic Value_3Y_min--38.678--------
Intrinsic Value_5Y_max--78.674--------
Intrinsic Value_5Y_min--72.415--------
Market Cap20376337488.000-15%23468797023.00030342112323.750-23%24263094210.122-3%20165163744.343+16%11684867545.300+101%
Net Profit Margin--0.2550.2560%0.243+5%0.225+13%0.164+56%
Operating Margin---0.080-100%0.311-100%0.275-100%0.147-100%
Operating Ratio--1.0971.078+2%1.077+2%1.118-2%0.803+37%
Pb Ratio6.095-15%7.02010.303-32%9.806-28%8.751-20%5.599+25%
Pe Ratio20.124-15%23.17829.185-21%28.742-19%30.279-23%32.908-30%
Price Per Share240.500-15%277.000358.125-23%286.375-3%238.008+16%137.915+101%
Price To Free Cash Flow Ratio14.459-15%16.65332.965-49%39.118-57%39.256-58%19.628-15%
Price To Total Gains Ratio120.134-15%138.36752.599+163%88.950+56%67.112+106%88.927+56%
Quick Ratio--1.1361.071+6%1.105+3%1.117+2%0.937+21%
Return On Assets--0.0490.053-6%0.051-3%0.042+19%0.028+75%
Return On Equity--0.0800.093-15%0.091-13%0.074+8%0.048+66%
Total Gains Per Share--2.0021.519+32%3.720-46%3.025-34%1.932+4%
Usd Book Value--102629332.50092291076.800+11%76515528.750+34%67896919.735+51%53502240.800+92%
Usd Book Value Change Per Share--0.0610.047+32%0.045+36%0.031+96%0.021+196%
Usd Book Value Per Share--1.2111.089+11%0.903+34%0.801+51%0.631+92%
Usd Dividend Per Share----0%0.069-100%0.061-100%0.039-100%
Usd Eps--0.0920.094-3%0.077+19%0.058+58%0.034+169%
Usd Free Cash Flow--10816131.9008283719.600+31%5950696.125+82%4553264.360+138%2276632.180+375%
Usd Free Cash Flow Per Share--0.1280.098+31%0.070+82%0.067+90%0.067+90%
Usd Free Cash Flow To Equity Per Share--0.1280.090+42%0.021+498%0.035+261%0.035+261%
Usd Market Cap625553560.882-15%720492068.606931502848.339-23%744876992.251-3%619070526.951+16%358725433.641+101%
Usd Price Per Share7.383-15%8.50410.994-23%8.792-3%7.307+16%4.234+101%
Usd Profit--7771336.6008021096.450-3%6526758.600+19%4930624.155+58%2892045.915+169%
Usd Revenue--30481293.20031331314.800-3%26816887.475+14%20999159.190+45%14608004.793+109%
Usd Total Gains Per Share--0.0610.047+32%0.114-46%0.093-34%0.059+4%
 EOD+4 -4MRQTTM+21 -12YOY+24 -115Y+29 -610Y+29 -6

3.2. Fundamental Score

Let's check the fundamental score of Universal Vision Biotechnology Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1520.124
Price to Book Ratio (EOD)Between0-16.095
Net Profit Margin (MRQ)Greater than00.255
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.136
Current Ratio (MRQ)Greater than12.522
Debt to Asset Ratio (MRQ)Less than10.348
Debt to Equity Ratio (MRQ)Less than10.563
Return on Equity (MRQ)Greater than0.150.080
Return on Assets (MRQ)Greater than0.050.049
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Universal Vision Biotechnology Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.645
Ma 20Greater thanMa 50257.335
Ma 50Greater thanMa 100268.921
Ma 100Greater thanMa 200271.776
OpenGreater thanClose243.500
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in TWD. All numbers in thousands.

Summary
Total Assets5,130,584
Total Liabilities1,787,609
Total Stockholder Equity3,177,642
 As reported
Total Liabilities 1,787,609
Total Stockholder Equity+ 3,177,642
Total Assets = 5,130,584

Assets

Total Assets5,130,584
Total Current Assets2,579,876
Long-term Assets2,550,708
Total Current Assets
Cash And Cash Equivalents 1,062,545
Short-term Investments 578,363
Net Receivables 584,252
Inventory 294,521
Other Current Assets 58,030
Total Current Assets  (as reported)2,579,876
Total Current Assets  (calculated)2,577,711
+/- 2,165
Long-term Assets
Property Plant Equipment 2,417,501
Long-term Assets Other 3,882
Long-term Assets  (as reported)2,550,708
Long-term Assets  (calculated)2,421,383
+/- 129,325

Liabilities & Shareholders' Equity

Total Current Liabilities1,023,088
Long-term Liabilities764,521
Total Stockholder Equity3,177,642
Total Current Liabilities
Short Long Term Debt 9,971
Accounts payable 312,308
Other Current Liabilities 29,119
Total Current Liabilities  (as reported)1,023,088
Total Current Liabilities  (calculated)351,398
+/- 671,690
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt768,290
Long-term Liabilities  (as reported)764,521
Long-term Liabilities  (calculated)768,290
+/- 3,769
Total Stockholder Equity
Retained Earnings 1,676,197
Total Stockholder Equity (as reported)3,177,642
Total Stockholder Equity (calculated)1,676,197
+/- 1,501,445
Other
Capital Stock847,249
Common Stock Shares Outstanding 84,725
Net Invested Capital 3,187,613
Net Working Capital 1,556,788
Property Plant and Equipment Gross 2,417,501



Balance Sheet

Currency in TWD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-06-302006-03-312005-06-302004-06-30
> Total Assets 
425,168
433,570
594,978
641,315
1,182,028
1,174,982
1,141,456
1,089,995
1,224,035
1,051,870
1,084,807
1,118,029
1,170,445
1,185,065
1,006,998
1,010,927
1,114,439
1,115,283
1,139,820
1,383,586
1,340,119
1,294,209
1,282,672
1,256,686
1,286,274
1,290,009
1,331,698
1,431,344
1,733,475
1,735,455
1,802,672
1,849,072
1,813,457
1,891,671
1,889,865
1,815,990
1,797,765
1,743,856
1,742,737
1,707,553
1,831,424
1,924,297
2,004,293
2,023,170
2,136,732
2,059,937
2,096,828
2,707,785
2,693,710
2,646,298
2,647,178
2,745,084
2,920,591
3,119,141
3,169,144
3,260,132
3,557,712
3,532,015
3,749,650
4,075,938
4,017,890
4,171,104
4,490,191
4,875,380
5,004,066
4,840,562
5,130,584
5,130,5844,840,5625,004,0664,875,3804,490,1914,171,1044,017,8904,075,9383,749,6503,532,0153,557,7123,260,1323,169,1443,119,1412,920,5912,745,0842,647,1782,646,2982,693,7102,707,7852,096,8282,059,9372,136,7322,023,1702,004,2931,924,2971,831,4241,707,5531,742,7371,743,8561,797,7651,815,9901,889,8651,891,6711,813,4571,849,0721,802,6721,735,4551,733,4751,431,3441,331,6981,290,0091,286,2741,256,6861,282,6721,294,2091,340,1191,383,5861,139,8201,115,2831,114,4391,010,9271,006,9981,185,0651,170,4451,118,0291,084,8071,051,8701,224,0351,089,9951,141,4561,174,9821,182,028641,315594,978433,570425,168
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,319,034
1,244,960
1,276,187
1,332,958
1,287,535
1,225,829
1,220,632
1,325,517
1,501,461
1,651,633
1,642,073
1,684,847
1,777,913
1,643,052
1,779,107
2,020,181
1,796,693
1,868,639
2,158,980
2,495,793
2,594,214
2,325,323
2,579,876
2,579,8762,325,3232,594,2142,495,7932,158,9801,868,6391,796,6932,020,1811,779,1071,643,0521,777,9131,684,8471,642,0731,651,6331,501,4611,325,5171,220,6321,225,8291,287,5351,332,9581,276,1871,244,9601,319,03400000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
617,822
409,941
466,349
412,379
266,690
476,039
372,135
473,091
506,968
521,109
616,002
707,127
810,937
650,882
534,192
774,990
503,653
681,300
703,019
1,003,652
965,590
688,237
1,062,545
1,062,545688,237965,5901,003,652703,019681,300503,653774,990534,192650,882810,937707,127616,002521,109506,968473,091372,135476,039266,690412,379466,349409,941617,82200000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
212,810
350,432
323,333
445,760
488,418
238,970
338,971
346,171
460,801
560,271
461,751
304,805
199,604
287,220
505,810
502,645
553,930
401,040
576,620
615,050
760,820
718,310
578,363
578,363718,310760,820615,050576,620401,040553,930502,645505,810287,220199,604304,805461,751560,271460,801346,171338,971238,970488,418445,760323,333350,432212,81000000000000000000000000000000000000000000000
       Net Receivables 
34,984
88,161
119,678
121,595
148,225
154,895
141,289
147,242
148,629
156,468
165,055
181,518
181,244
179,053
175,444
182,853
184,182
187,611
180,796
197,413
210,392
3,391
231,914
247,146
246,243
247,119
241,950
261,059
269,313
281,239
293,953
299,311
299,268
312,340
306,097
302,379
311,171
311,878
309,452
300,651
303,747
302,262
319,829
315,772
325,925
329,286
324,061
319,183
337,665
340,787
385,000
373,801
398,959
427,443
410,921
515,259
605,405
526,532
546,245
509,207
498,288
513,025
585,182
542,744
525,903
556,846
584,252
584,252556,846525,903542,744585,182513,025498,288509,207546,245526,532605,405515,259410,921427,443398,959373,801385,000340,787337,665319,183324,061329,286325,925315,772319,829302,262303,747300,651309,452311,878311,171302,379306,097312,340299,268299,311293,953281,239269,313261,059241,950247,119246,243247,146231,9143,391210,392197,413180,796187,611184,182182,853175,444179,053181,244181,518165,055156,468148,629147,242141,289154,895148,225121,595119,67888,16134,984
       Inventory 
0
0
3,072
24,304
0
84,043
144,160
134,862
131,323
116,379
120,123
115,196
112,017
110,673
122,467
107,493
107,247
116,257
127,487
138,181
148,800
154,506
147,796
109,705
114,355
104,638
102,458
103,121
94,103
86,935
83,439
80,074
93,637
85,756
78,912
82,360
75,649
70,073
75,788
66,616
65,209
60,874
55,095
64,373
69,361
62,297
59,909
58,946
60,501
60,738
61,022
57,796
62,437
66,855
62,620
76,741
83,991
92,508
115,651
140,934
171,240
195,233
227,620
262,818
280,275
294,231
294,521
294,521294,231280,275262,818227,620195,233171,240140,934115,65192,50883,99176,74162,62066,85562,43757,79661,02260,73860,50158,94659,90962,29769,36164,37355,09560,87465,20966,61675,78870,07375,64982,36078,91285,75693,63780,07483,43986,93594,103103,121102,458104,638114,355109,705147,796154,506148,800138,181127,487116,257107,247107,493122,467110,673112,017115,196120,123116,379131,323134,862144,16084,043024,3043,07200
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,374,827
1,406,175
1,420,469
1,426,546
1,419,567
1,419,130
1,467,508
1,527,071
1,575,285
1,779,799
1,888,963
1,970,543
2,055,757
2,221,197
2,302,465
2,331,211
2,379,587
2,409,852
2,515,239
2,550,708
2,550,7082,515,2392,409,8522,379,5872,331,2112,302,4652,221,1972,055,7571,970,5431,888,9631,779,7991,575,2851,527,0711,467,5081,419,1301,419,5671,426,5461,420,4691,406,1751,374,82700000000000000000000000000000000000000000000000
       Property Plant Equipment 
215,227
218,661
208,522
166,504
193,557
191,536
231,672
220,754
211,897
200,871
195,888
216,656
448,232
470,872
466,202
459,665
447,845
462,250
455,028
501,378
503,476
503,884
511,444
511,040
540,819
526,147
524,154
569,312
557,319
583,480
645,353
678,115
675,875
788,926
812,880
792,956
789,353
774,299
771,577
752,361
741,778
732,755
730,518
768,110
745,717
727,005
735,611
1,281,749
1,297,181
1,284,775
1,312,277
1,298,967
1,281,614
1,312,557
1,412,976
1,434,616
1,653,822
1,686,974
1,723,908
1,822,186
1,956,759
2,191,134
2,220,089
2,270,873
2,296,853
2,406,940
2,417,501
2,417,5012,406,9402,296,8532,270,8732,220,0892,191,1341,956,7591,822,1861,723,9081,686,9741,653,8221,434,6161,412,9761,312,5571,281,6141,298,9671,312,2771,284,7751,297,1811,281,749735,611727,005745,717768,110730,518732,755741,778752,361771,577774,299789,353792,956812,880788,926675,875678,115645,353583,480557,319569,312524,154526,147540,819511,040511,444503,884503,476501,378455,028462,250447,845459,665466,202470,872448,232216,656195,888200,871211,897220,754231,672191,536193,557166,504208,522218,661215,227
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,331
3,013
2,703
2,882
2,679
2,439
2,287
2,186
1,931
1,693
1,554
5,206
5,033
5,559
5,247
5,857
5,592
5,403
5,396
5,230
5,345
5,093
4,681
5,270
5,337
5,818
7,029
7,252
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000007,2527,0295,8185,3375,2704,6815,0935,3455,2305,3965,4035,5925,8575,2475,5595,0335,2061,5541,6931,9312,1862,2872,4392,6792,8822,7033,0133,33100000000000000000000000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,374,827
1,406,175
1,420,469
1,426,546
1,419,567
0
0
3,273
2,646
4,021
3,343
2,655
2,055
7,971
7,353
6,563
6,038
5,201
4,724
3,882
3,8824,7245,2016,0386,5637,3537,9712,0552,6553,3434,0212,6463,273001,419,5671,426,5461,420,4691,406,1751,374,82700000000000000000000000000000000000000000000000
> Total Liabilities 
157,852
75,917
63,576
68,773
527,315
577,115
545,381
550,776
682,776
528,278
400,646
436,734
521,520
547,962
371,483
347,162
410,920
390,921
407,911
244,781
199,034
208,689
221,975
238,354
268,089
262,204
277,041
305,412
654,240
626,538
662,013
691,861
706,561
757,391
740,117
661,284
692,129
630,373
582,884
544,154
463,158
408,945
421,586
426,092
595,691
496,013
487,912
1,059,432
1,082,543
998,087
951,831
1,123,758
1,187,297
1,220,406
1,129,697
1,388,549
1,554,926
1,392,584
1,421,155
1,890,230
1,651,641
1,581,737
1,662,065
2,247,439
2,123,452
1,667,196
1,787,609
1,787,6091,667,1962,123,4522,247,4391,662,0651,581,7371,651,6411,890,2301,421,1551,392,5841,554,9261,388,5491,129,6971,220,4061,187,2971,123,758951,831998,0871,082,5431,059,432487,912496,013595,691426,092421,586408,945463,158544,154582,884630,373692,129661,284740,117757,391706,561691,861662,013626,538654,240305,412277,041262,204268,089238,354221,975208,689199,034244,781407,911390,921410,920347,162371,483547,962521,520436,734400,646528,278682,776550,776545,381577,115527,31568,77363,57675,917157,852
   > Total Current Liabilities 
36,550
52,639
42,969
54,435
69,236
106,389
101,690
101,260
671,673
519,020
390,812
436,355
521,345
486,323
309,414
284,428
375,259
371,189
387,992
210,648
160,776
174,791
189,788
211,993
205,928
213,986
235,381
229,539
582,541
558,516
557,916
563,600
584,006
545,064
549,472
489,596
532,796
484,664
473,834
449,029
383,620
344,887
375,340
379,252
557,821
466,357
465,111
613,211
615,173
560,365
525,701
717,885
795,360
846,595
753,412
982,971
951,969
738,543
731,657
1,208,765
906,147
797,385
910,382
1,462,837
1,365,751
900,582
1,023,088
1,023,088900,5821,365,7511,462,837910,382797,385906,1471,208,765731,657738,543951,969982,971753,412846,595795,360717,885525,701560,365615,173613,211465,111466,357557,821379,252375,340344,887383,620449,029473,834484,664532,796489,596549,472545,064584,006563,600557,916558,516582,541229,539235,381213,986205,928211,993189,788174,791160,776210,648387,992371,189375,259284,428309,414486,323521,345436,355390,812519,020671,673101,260101,690106,38969,23654,43542,96952,63936,550
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
153,214
83,862
83,809
80,946
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000080,94683,80983,862153,21400000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
153,214
83,862
83,809
80,946
81,608
320,001
328,571
176,896
77,045
384,192
138,932
9,030
9,379
139,211
9,302
9,172
7,578
5,775
3,685
9,971
9,9713,6855,7757,5789,1729,302139,2119,3799,030138,932384,19277,045176,896328,571320,00181,60880,94683,80983,862153,21400000000000000000000000000000000000000000000000
       Accounts payable 
11,487
19,211
13,928
30,735
36,910
32,027
65,775
65,186
38,921
37,399
46,622
35,742
40,833
48,107
45,547
38,919
41,117
30,207
41,898
56,421
49,003
54,689
48,593
49,358
40,337
43,005
48,098
53,599
43,904
49,274
51,827
54,768
45,854
50,954
51,032
64,873
65,211
57,998
53,258
51,919
54,412
59,428
55,678
79,806
66,990
61,906
62,126
80,608
89,175
121,703
76,476
94,957
112,309
117,071
122,934
130,435
158,521
161,801
210,497
258,339
253,903
233,053
254,552
303,118
278,232
273,862
312,308
312,308273,862278,232303,118254,552233,053253,903258,339210,497161,801158,521130,435122,934117,071112,30994,95776,476121,70389,17580,60862,12661,90666,99079,80655,67859,42854,41251,91953,25857,99865,21164,87351,03250,95445,85454,76851,82749,27443,90453,59948,09843,00540,33749,35848,59354,68949,00356,42141,89830,20741,11738,91945,54748,10740,83335,74246,62237,39938,92165,18665,77532,02736,91030,73513,92819,21111,487
       Other Current Liabilities 
25,063
33,428
29,041
23,700
32,326
74,362
35,915
31,074
24,908
31,861
25,127
33,895
29,689
33,216
28,867
40,509
34,142
40,982
46,094
74,227
61,773
90,102
101,195
82,635
85,591
90,981
107,283
69,181
136,037
106,642
133,489
155,163
224,878
180,836
190,093
181,370
237,585
161,666
180,576
167,110
279,208
185,459
219,662
229,446
294,146
174,569
195,397
13,202
10,874
17,670
183,710
374,232
192,367
203,135
226,496
572,846
200,102
190,076
218,688
681,308
250,409
258,085
505,204
836,131
759,821
36,773
29,119
29,11936,773759,821836,131505,204258,085250,409681,308218,688190,076200,102572,846226,496203,135192,367374,232183,71017,67010,87413,202195,397174,569294,146229,446219,662185,459279,208167,110180,576161,666237,585181,370190,093180,836224,878155,163133,489106,642136,03769,181107,28390,98185,59182,635101,19590,10261,77374,22746,09440,98234,14240,50928,86733,21629,68933,89525,12731,86124,90831,07435,91574,36232,32623,70029,04133,42825,063
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
446,221
467,370
437,722
426,130
405,873
391,937
373,811
376,285
405,578
602,957
654,041
689,498
681,465
745,494
784,352
751,683
784,602
757,701
766,614
764,521
764,521766,614757,701784,602751,683784,352745,494681,465689,498654,041602,957405,578376,285373,811391,937405,873426,130437,722467,370446,22100000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
383,805
459,839
432,393
420,845
469,060
459,869
446,840
437,242
463,874
666,617
703,641
748,166
750,382
797,867
797,348
773,151
822,724
801,247
806,425
768,290
768,290806,425801,247822,724773,151797,348797,867750,382748,166703,641666,617463,874437,242446,840459,869469,060420,845432,393459,839383,80500000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
515
505
505
505
505
505
505
505
505
755
75
535
535
535
535
535
588
578
562
543
5435625785885355355355355357575550550550550550550550550551500000000000000000000000000000000000000000000000
> Total Stockholder Equity
267,316
357,653
531,402
572,542
654,713
597,867
596,075
539,219
541,259
523,592
684,161
681,295
648,925
637,103
635,515
663,765
703,519
724,362
731,909
1,138,805
1,141,085
1,085,520
1,060,697
1,018,332
1,018,185
1,027,805
1,054,657
1,125,932
1,079,235
1,108,917
1,140,659
1,157,211
1,106,670
1,134,043
1,149,748
1,154,706
1,105,636
1,113,483
1,159,853
1,163,399
1,332,938
1,375,243
1,407,029
1,429,244
1,385,022
1,422,505
1,476,752
1,525,085
1,501,894
1,540,374
1,591,358
1,527,542
1,638,742
1,781,782
1,913,899
1,742,249
1,867,599
2,000,540
2,188,362
2,034,759
2,215,090
2,425,198
2,663,464
2,451,765
2,701,116
2,983,276
3,177,642
3,177,6422,983,2762,701,1162,451,7652,663,4642,425,1982,215,0902,034,7592,188,3622,000,5401,867,5991,742,2491,913,8991,781,7821,638,7421,527,5421,591,3581,540,3741,501,8941,525,0851,476,7521,422,5051,385,0221,429,2441,407,0291,375,2431,332,9381,163,3991,159,8531,113,4831,105,6361,154,7061,149,7481,134,0431,106,6701,157,2111,140,6591,108,9171,079,2351,125,9321,054,6571,027,8051,018,1851,018,3321,060,6971,085,5201,141,0851,138,805731,909724,362703,519663,765635,515637,103648,925681,295684,161523,592541,259539,219596,075597,867654,713572,542531,402357,653267,316
   Common Stock
200,000
220,000
313,959
346,698
401,650
401,650
401,764
401,764
401,764
402,180
452,040
452,735
452,735
452,735
452,735
452,735
460,818
465,540
465,540
665,540
665,540
665,540
661,800
661,800
661,230
661,230
661,230
661,230
661,230
661,230
661,230
661,230
661,230
661,230
661,230
661,230
661,230
661,230
661,230
661,230
761,230
761,230
761,230
761,230
761,230
761,230
761,230
761,230
761,230
761,230
761,230
761,230
761,230
761,230
761,230
761,230
761,230
761,230
761,230
761,230
761,230
799,292
799,292
0
799,292
0
0
00799,2920799,292799,292761,230761,230761,230761,230761,230761,230761,230761,230761,230761,230761,230761,230761,230761,230761,230761,230761,230761,230761,230761,230761,230661,230661,230661,230661,230661,230661,230661,230661,230661,230661,230661,230661,230661,230661,230661,230661,230661,800661,800665,540665,540665,540465,540465,540460,818452,735452,735452,735452,735452,735452,040402,180401,764401,764401,764401,650401,650346,698313,959220,000200,000
   Retained Earnings 
34,687
58,743
92,492
86,879
75,943
12,587
23,624
0
0
0
0
0
0
0
0
0
0
0
0
27,982
31,016
0
0
0
0
6,177
33,184
103,511
57,962
86,081
111,931
130,327
80,964
105,650
123,570
129,914
83,545
95,272
142,639
152,969
147,020
188,681
221,851
242,456
247,955
287,631
341,461
333,687
295,275
337,231
462,292
399,405
514,394
652,972
779,864
609,582
737,086
871,498
1,055,575
888,302
1,037,286
1,243,642
1,487,290
1,069,790
1,485,534
1,468,058
1,676,197
1,676,1971,468,0581,485,5341,069,7901,487,2901,243,6421,037,286888,3021,055,575871,498737,086609,582779,864652,972514,394399,405462,292337,231295,275333,687341,461287,631247,955242,456221,851188,681147,020152,969142,63995,27283,545129,914123,570105,65080,964130,327111,93186,08157,962103,51133,1846,177000031,01627,98200000000000023,62412,58775,94386,87992,49258,74334,687
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000-1,14100000000-28,970-28,970-28,970-28,970-28,970-38,320-38,320-38,320-14,814000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-6,087
-8,280
-7,863
-6,313
-7,647
-11,123
-14,088
-15,017
-18,806
-14,344
-9,119
-10,487
-12,641
-14,112
-10,367
3,303
34,650
340
-5,042
0
34,366
0
0
0034,3660-5,04234034,6503,303-10,367-14,112-12,641-10,487-9,119-14,344-18,806-15,017-14,088-11,123-7,647-6,313-7,863-8,280-6,08700000000000000000000000000000000000000000000



Balance Sheet

Currency in TWD. All numbers in thousands.




Cash Flow

Currency in TWD. All numbers in thousands.




Income Statement

Currency in TWD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue4,082,256
Cost of Revenue-1,633,886
Gross Profit2,448,3702,448,370
 
Operating Income (+$)
Gross Profit2,448,370
Operating Expense-2,766,042
Operating Income1,316,214-317,672
 
Operating Expense (+$)
Research Development-
Selling General Administrative1,132,156
Selling And Marketing Expenses-
Operating Expense2,766,0421,132,156
 
Net Interest Income (+$)
Interest Income19,158
Interest Expense-15,833
Other Finance Cost-0
Net Interest Income3,325
 
Pretax Income (+$)
Operating Income1,316,214
Net Interest Income3,325
Other Non-Operating Income Expenses-
Income Before Tax (EBT)1,318,5791,316,214
EBIT - interestExpense = -15,833
1,045,094
1,060,927
Interest Expense15,833
Earnings Before Interest and Taxes (EBIT)-1,334,412
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax1,318,579
Tax Provision-254,555
Net Income From Continuing Ops1,064,0241,064,024
Net Income1,045,094
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--3,325
 

Technical Analysis of Universal Vision Biotechnology Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Universal Vision Biotechnology Co Ltd. The general trend of Universal Vision Biotechnology Co Ltd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Universal Vision Biotechnology Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Universal Vision Biotechnology Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 247.98 < 256.89 < 259.81.

The bearish price targets are: 218.22 > 206.95 > 192.37.

Tweet this
Universal Vision Biotechnology Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Universal Vision Biotechnology Co Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Universal Vision Biotechnology Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Universal Vision Biotechnology Co Ltd. The current macd is -7.70239762.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Universal Vision Biotechnology Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Universal Vision Biotechnology Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Universal Vision Biotechnology Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Universal Vision Biotechnology Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartUniversal Vision Biotechnology Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Universal Vision Biotechnology Co Ltd. The current adx is 21.63.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Universal Vision Biotechnology Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Universal Vision Biotechnology Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Universal Vision Biotechnology Co Ltd. The current sar is 249.93.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Universal Vision Biotechnology Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Universal Vision Biotechnology Co Ltd. The current rsi is 33.64. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Universal Vision Biotechnology Co Ltd Daily Relative Strength Index (RSI) ChartUniversal Vision Biotechnology Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Universal Vision Biotechnology Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Universal Vision Biotechnology Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Universal Vision Biotechnology Co Ltd Daily Stochastic Oscillator ChartUniversal Vision Biotechnology Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Universal Vision Biotechnology Co Ltd. The current cci is -123.93565326.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Universal Vision Biotechnology Co Ltd Daily Commodity Channel Index (CCI) ChartUniversal Vision Biotechnology Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Universal Vision Biotechnology Co Ltd. The current cmo is -35.39107518.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Universal Vision Biotechnology Co Ltd Daily Chande Momentum Oscillator (CMO) ChartUniversal Vision Biotechnology Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Universal Vision Biotechnology Co Ltd. The current willr is -85.97374573.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Universal Vision Biotechnology Co Ltd Daily Williams %R ChartUniversal Vision Biotechnology Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Universal Vision Biotechnology Co Ltd.

Universal Vision Biotechnology Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Universal Vision Biotechnology Co Ltd. The current atr is 5.67347105.

Universal Vision Biotechnology Co Ltd Daily Average True Range (ATR) ChartUniversal Vision Biotechnology Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Universal Vision Biotechnology Co Ltd. The current obv is 17,919,498.

Universal Vision Biotechnology Co Ltd Daily On-Balance Volume (OBV) ChartUniversal Vision Biotechnology Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Universal Vision Biotechnology Co Ltd. The current mfi is 29.50.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Universal Vision Biotechnology Co Ltd Daily Money Flow Index (MFI) ChartUniversal Vision Biotechnology Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Universal Vision Biotechnology Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Universal Vision Biotechnology Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Universal Vision Biotechnology Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.645
Ma 20Greater thanMa 50257.335
Ma 50Greater thanMa 100268.921
Ma 100Greater thanMa 200271.776
OpenGreater thanClose243.500
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Universal Vision Biotechnology Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Universal Vision Biotechnology Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Universal Vision Biotechnology Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Universal Vision Biotechnology Co Ltd

I send you an email if I find something interesting about Universal Vision Biotechnology Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Universal Vision Biotechnology Co Ltd.

Receive notifications about Universal Vision Biotechnology Co Ltd in your mailbox!